CDR exhbited at booth # 320 at the world's leading forum on dementia research - Alzheimer's Association, International Conference on Alzheimer's Disease 2009, July 11th - 16th, Vienna, Austria. ICAD 2009 drew nearly 3,800 international atten ... Read more

CDR attended the 49th Annual NCDEU Meeting on June 29th - July 2nd, Hollywood, Florida, USA. NCDEU is an annual scientific meeting that brings together academic researchers involved in clinical trials, research pharmacists, clinicians ... Read more

 CDR attended the 3rd BioTrinity 2009 conference which united the UK’s life science industry. The largest biotech partnering and investment conference in the country was held on April 2 -3, 2009 Kassam Stadium, Oxford, UK whe ... Read more

CDR attended the International Congress on Sschizophrenia Research on March 28th - 1st April in San Diego, CA. The  biennial meeting where scientists representing a broad range of disciplines involved with discovery in schizophrenia gathere ... Read more

ASCPT 2009 CDR exhibited at booth # 128 at the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Washington, DC March 18th - 21st  2009. The 2009 Annual Meeting was held at the new Gaylo ... Read more

AD/PD 2009 CDR was proud to co-sponsor a symposium at the 2009 AD/PD conference with Forenap Pharma, 11-15th March 2009 in Prague, Czech Republic. The event focussed on Alzheimer’s and Parkinson’s Diseases: Advances, Concepts and New Challenge ... Read more

Prof. Gary Ford from Newcastle University presented the results of PRoFESS-COG, an international multicentre secondary stroke prevention trial that used the CDR System to assess the effects of telmisartan (an angiotensin-receptor-blocker) on cognitiv ... Read more

ISCTM 5th Annual Meeting CDR attended the International Society for CNS Clinical Trials and Methodology held in Arlington, Virginia on 3rd - 5th March 2009. The Scientific Program Committee had again developed a very ambitious and timely agenda fo ... Read more

Fantasy author Terry Pratchett diagnosed with Posterior Cortical Atrophy (PCA) a variant form of Alzheimer’s, chronicles his personal journey since he was diagnosed. Produced by IWC Media, the documentary follows Pratchett’s search through science for a c ... Read more

CDR attended NIO's third annual Public Policy Tour of Washington, DC which took place on Tuesday and Wednesday, February 10-11, 2009. The two-day event included high-level meetings on Capitol Hill and with the Department of Veterans Affairs and National I ... Read more

Helen Brooker and Nicole Meinel of CDR explain that assessing the cognitive effects of drugs at an early stage in clinical trials can reduce the likelihood of a drug failing at a later stage of development; thereby saving time and money. Click here ... Read more

Pat Turk, US Director of Business Development was recently interviewed by CeterWatch Weekly. The article covered the following topics; What differentiates CDR from other computerized cognitive testing services companies? What other se ... Read more

Dr Brian Saxby presented on "What would be the ideal design for a BP lowering trial (patients, drug, duration of follow-up)?" and presented the following posters; 'Candesartan and cognitive decline in older hypertensives from the SCOPE study: Comparison t ... Read more

Professor Keith Wesnes presented on "Cognitive Testing in Clinical Trials" at Visiongain's CNS Drug Development Conference held at BSG Conference Centre, London, 15th - 16th December 2008. The global CNS pharmaceuticals market, worth £55bn a year wi ... Read more

Professor Keith Wesnes presented on "Computerised Cognitive Function Assessment Comes of Age in Drug Development" & hosted a workshop titled "Assessing Cognitive Enhancement in Clinical Trials" at the Copthorne Tara Hotel, London, 25th - 27th Nov ... Read more